Bridging legacy DCS and modern automation
How automation and data standards can help pharmaceutical manufacturers reduce risk, improve flexibility, and modernize operations.
Pharmaceutical manufacturers are under increasing pressure to improve agility, scale production efficiently, and leverage data-driven decision-making while maintaining validated operations. Many facilities, however, continue to rely on legacy DCS environments that can limit flexibility, create vendor dependence, and make operational data difficult to access and use across the enterprise.
Modern automation approaches help address these challenges by introducing standards-based architectures, software abstraction, and unified data strategies. These technologies make it easier to integrate new equipment, support modular manufacturing, reduce modernization risk, and enable more flexible production without disrupting existing operations.
At the same time, contextualized and accessible data provides the foundation for advanced analytics, AI applications, predictive maintenance, and faster process optimization. Together, modern automation and data orchestration enable pharmaceutical manufacturers to reduce vendor lock-in, improve scalability, accelerate innovation, and prepare operations for future manufacturing demands.
Key takeaways:
- Reduce vendor lock-in and single-source risk through standards-based automation
- Integrate modular equipment more easily using MTP and software abstraction
- Improve access to contextualized production data for analytics and AI initiatives
- Scale processes more efficiently from R&D through commercial production
- Minimize validation and compliance risks when modernizing operations